Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Federal Trade Commission
Dow
Healthtrust
Argus Health
Cerilliant
Baxter
UBS
US Department of Justice
Accenture

Generated: October 20, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,344,658

« Back to Dashboard

Summary for Patent: 5,344,658

Title: Process and composition using ondansetron
Abstract:The invention relates to a process for reducing the crystal size of ondansetron hydrochloride dihydrate produced by crystallisation from solvent to a size which is suitable for effective distribution in a tablet blend, in particular 100% less that 250 .mu.m. The ondansetron hydrochloride dihydrate is desolvated by drying at elevated temperature and reduced or atmospheric pressure and is then rehydrated.
Inventor(s): Collin; David T. (Ware, GB2)
Assignee: Glaxo Group Limited (London, GB2)
Application Number:08/005,736
Patent Claim Types:
see list of patent claims
Compound; Dosage form; Process; Composition;

No matches for this query

Foreign Priority and PCT Information for Patent: 5,344,658

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom89148043Jun 28, 1989

International Patent Family for Patent: 5,344,658

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada2019944► Subscribe
Germany69011786► Subscribe
Denmark0415522► Subscribe
European Patent Office0415522► Subscribe
Spain2060045► Subscribe
United Kingdom8914804► Subscribe
Hong Kong44495► Subscribe
HungaryT54140► Subscribe
Hungary904015► Subscribe
Australia5787490► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Julphar
McKesson
Fish and Richardson
AstraZeneca
QuintilesIMS
Fuji
Novartis
Farmers Insurance
Daiichi Sankyo
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot